Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/27/22
End: 05/31/27
Due: 05/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients | NCT05532696 | Anbogen Therapeutics, Inc. | user2@example.com | None | 2022-09-27 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |